<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Reports of Biochemistry and Molecular Biology</title>
<title_fa></title_fa>
<short_title>rbmb.net</short_title>
<subject>Basic Sciences</subject>
<web_url>http://rbmb.net</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-3480</journal_id_issn>
<journal_id_issn_online>2322-3480</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/rbmb</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Regulation of Focal Adhesion Dynamics and Cell Migration by PLC/PI3K-Mediated Metabolism of PtdIns (4,5) P2 in a Breast Cancer Cell Line</title>
	<subject_fa>زیست شناسی سلولی</subject_fa>
	<subject>Cell Biology</subject>
	<content_type_fa>مقالات اصلی</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;em&gt;Background: &lt;/em&gt;&lt;/strong&gt;Focal adhesions (FAs) are highly dynamic complex structures that assembled and&amp;nbsp;disassembled on an ongoing basis. The balance between the two processes mediates various aspects of cell&amp;nbsp;behavior, ranging from cell adhesion to cell migration. Assembly and disassembly processes of FAs are&lt;br&gt;
regulated by a variety of cellular signaling proteins and adaptors. We previously demonstrated that local&amp;nbsp;levels of Phosphatidylinositol 4,5‐bisphosphate (PtdIns(4,5)P2) in MDA-MB-231 cells increases during FA&amp;nbsp;assembly and declines during disassembly. In this study we aimed to investigate whether PtdIns(4,5)P2&amp;nbsp;regulates FA turnover.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Methods:&lt;/em&gt;&lt;/strong&gt; MDA-MB-231 cells were co-transfected with a labeling vinculin (or zyxin) and the PLC𝛅1-PH&amp;nbsp;biosensor to visualize FA localization and PtdIns(4,5)P2 in the cell membrane. We also used&amp;nbsp;pharmacological inhibitors to determine the mechanism underlying the changes of PtdIns(4,5)P2 level&lt;br&gt;
during FA turnover and cell migration. Immunostaining, immunoprecipitation, and Western blotting were&amp;nbsp;used to examine the localization and interaction between phospholipase C (PLC)/phosphatidylinositol 3-kinase (PI3K) FA proteins.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Results: &lt;/em&gt;&lt;/strong&gt;We showed that inhibition of PLC, PI3K significantly reduced the decline of PtdIns(4,5)P2 levels&amp;nbsp;within FA disassembly and the slowdown rate of FA turnover and cell migration. We also showed that the&amp;nbsp;inhibition of enzymes implicated in the downstream pathway of PtdIns(4,5)P2, such as diacylglycerol kinase&amp;nbsp;(DAGK) and protein kinase C (PKC) significantly reduced FA turnover time and the speed of cell migration.&amp;nbsp;Additionally, we demonstrated that PLC but not PI3K interact with FAs. In conclusion,&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Conclusions:&lt;/em&gt;&lt;/strong&gt; This study suggests that dynamical changes of PtdIns(4,5)P2 might regulate FA turnover and&amp;nbsp;facilitate cell migration.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cell Migration, Focal Adhesion Turnover, MDA-MB-231 Breast Cancer Cell Line,
Ptdins(4,5)P2, PLC, PI3K.</keyword>
	<start_page>270</start_page>
	<end_page>281</end_page>
	<web_url>http://rbmb.net/browse.php?a_code=A-10-749-6&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Dhurgham</first_name>
	<middle_name></middle_name>
	<last_name>Al-Fahad</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dhurgham.alfahad@sci.utq.edu.iq</email>
	<code>100319475328460012213</code>
	<orcid>100319475328460012213</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pharmaceutical Sciences, College of Pharmacy University of Thi-Qar, Iraq</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Firas</first_name>
	<middle_name></middle_name>
	<last_name>Alyaseen</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012214</code>
	<orcid>100319475328460012214</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmaceutical Sciences, College of Pharmacy University of Thi-Qar, Iraq.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ahmed</first_name>
	<middle_name></middle_name>
	<last_name>Al-Amery</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012215</code>
	<orcid>100319475328460012215</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Faculty of Education, Soran University, Erbil, Kurdistan Region, Iraq.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Clementino</first_name>
	<middle_name></middle_name>
	<last_name>Ibeas Bin</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012216</code>
	<orcid>100319475328460012216</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Ilumix Biotech Ltd, London, United Kingdom.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
